These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22881192)

  • 1. Successful long-term enzyme replacement therapy in a young adult with Fabry disease.
    Kampmann C; Kalkum G; Beck M; Whybra C
    Clin Genet; 2013 Apr; 83(4):395-6. PubMed ID: 22881192
    [No Abstract]   [Full Text] [Related]  

  • 2. Beneficial effects of long-term enzyme replacement therapy in a child with Fabry disease.
    Martin-Suárez I; Suárez-Marrero C
    Int J Clin Pract; 2010 Jun; 64(7):995. PubMed ID: 20584233
    [No Abstract]   [Full Text] [Related]  

  • 3. Enzyme-replacement therapy for Anderson-Fabry disease.
    Pastores GM; Thadhani R
    Lancet; 2001 Aug; 358(9282):601-3. PubMed ID: 11530143
    [No Abstract]   [Full Text] [Related]  

  • 4. Thyroid function in Fabry disease before and after enzyme replacement therapy.
    Faggiano A; Severino R; Ramundo V; Russo R; Vuolo L; Del Prete M; Marciello F; Lombardi G; Cianciaruso B; Colao A; Pisani A
    Minerva Endocrinol; 2011 Mar; 36(1):1-5. PubMed ID: 21460782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical Response to Enzyme Replacement Therapy of Fabry Disease Cardiomyopathy.
    Frustaci A; Russo MA; Chimenti C
    Circ Cardiovasc Imaging; 2016 Aug; 9(8):. PubMed ID: 27486136
    [No Abstract]   [Full Text] [Related]  

  • 6. Does enzyme replacement therapy improve symptoms of Fabry disease in patients undergoing dialysis?
    Banikazemi M; Desnick RJ
    Nat Clin Pract Nephrol; 2006 Feb; 2(2):72-3. PubMed ID: 16932395
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fabry's disease. An orphan disease that has found a solution: enzymatic replacement with alpha-galactosidase].
    Selgas R; García de Lorenzo A; Valdés F; Beck M
    Nefrologia; 2001; 21(5):443-7. PubMed ID: 11795012
    [No Abstract]   [Full Text] [Related]  

  • 8. Enzyme replacement therapy and Fabry kidney disease: quo vadis?
    Warnock DG
    J Am Soc Nephrol; 2007 May; 18(5):1368-70. PubMed ID: 17429046
    [No Abstract]   [Full Text] [Related]  

  • 9. Enzyme replacement therapy for Fabry's disease.
    Waldek S; Germain DP; Wanner C; Warnock DG
    Lancet; 2010 May; 375(9725):1523; author reply 1523-4. PubMed ID: 20435225
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune response to enzyme replacement therapy in Fabry disease: impact on clinical outcome?
    Hollak CE; Linthorst GE
    Mol Genet Metab; 2009 Jan; 96(1):1-3. PubMed ID: 19062323
    [No Abstract]   [Full Text] [Related]  

  • 11. Enzyme replacement therapy for Fabry's disease.
    Deegan P
    Lancet; 2010 May; 375(9725):1522-3; author reply 1523-4. PubMed ID: 20435224
    [No Abstract]   [Full Text] [Related]  

  • 12. [Enzyme therapy in Fabry disease: when scarcity of one enzyme illustrates the vulnerability of biotech].
    Lidove O; Choukroun G; Bekri S; Viot G; Tsimaratos M; Joly D
    Presse Med; 2010 May; 39(5):527-9. PubMed ID: 20194001
    [No Abstract]   [Full Text] [Related]  

  • 13. Enzyme replacement in the treatment of Fabry's disease. Is there a point-of-no-return?
    del Toro N; Milán JA; Palma A
    Nephrol Dial Transplant; 2004 Apr; 19(4):1018. PubMed ID: 15031378
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurological features of Fabry disease: clinical, pathophysiological aspects and therapy.
    Bersano A; Lanfranconi S; Valcarenghi C; Bresolin N; Micieli G; Baron P
    Acta Neurol Scand; 2012 Aug; 126(2):77-97. PubMed ID: 22428782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do we need more intensive enzyme replacement therapy for Anderson-Fabry disease?
    Basic-Jukic N; Kes P; Mokos I; Coric M
    Med Hypotheses; 2009 Apr; 72(4):476-7. PubMed ID: 19124204
    [No Abstract]   [Full Text] [Related]  

  • 16. Enzyme replacement therapy and Fabry nephropathy.
    Warnock DG; Daina E; Remuzzi G; West M
    Clin J Am Soc Nephrol; 2010 Feb; 5(2):371-8. PubMed ID: 20007680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabry disease in children and response to enzyme replacement therapy: results from the Fabry Outcome Survey.
    Ramaswami U; Parini R; Pintos-Morell G; Kalkum G; Kampmann C; Beck M;
    Clin Genet; 2012 May; 81(5):485-90. PubMed ID: 21457233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anderson-Fabry disease: enzyme replacement therapy.
    Leon-Mateos A; Fernández-Redondo V; Beiras A; Toribio J
    Acta Derm Venereol; 2004; 84(1):88-9. PubMed ID: 15040494
    [No Abstract]   [Full Text] [Related]  

  • 19. Fabry disease: is there a role for enzyme replacement therapy?
    Mehta AB
    J Intern Med; 2013 Oct; 274(4):329-30. PubMed ID: 23662843
    [No Abstract]   [Full Text] [Related]  

  • 20. Enzyme replacement therapy in Fabry disease in Poland: a position statement.
    Nowicki M; Bazan-Socha S; Błażejewska-Hyzorek B; Gellert R; Imiela J; Kaźmierczak J; Kłopotowski M; Oko-Sarnowska Z; Pawlaczyk K; Ponikowski P; Sławek J; Sykut-Cegielska J; Witkowski A; Zwolińska D
    Pol Arch Intern Med; 2020 Jan; 130(1):91-97. PubMed ID: 31868861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.